Can green tea prevent atherosclerotic CVD? Read the week’s top stories in cardiology
Click Here to Manage Email Alerts
The top story in cardiology last week was about a study that showed green tea lowered the risk for atherosclerotic CVD in the Chinese population.
A guest commentary that discussed the link between the way physicians “are forced to practice medicine” and the recent uptick in CVD-related deaths was also at the top of the list.
Read these stories and more cardiology news below.
Green tea may lower risk for ASCVD, mortality in Chinese population
Habitual drinking of tea, particularly green tea, confers a significant reduction in risk for atherosclerotic CVD and all-cause mortality, according to research published in the European Journal of Preventive Cardiology. Read more.
Losing the battle against heart disease
In this guest commentary, Dharmesh Patel, MD, examines how the practice of medicine has led to recent increases in CVD deaths. Read more.
FDA approves less-invasive approach for heart pump implantation
Abbott announced that an alternative, less-invasive surgical technique for the implantation of a left ventricular assist device has been approved by the FDA. Read more.
AHA: Time plays critical role in diagnosis, treatment of fulminant myocarditis
The timely diagnosis and treatment of patients with fulminant myocarditis is critical for favorable outcomes, according to a scientific statement by the American Heart Association published in Circulation. Read more.
First-time marathon runners experience improved BP, aortic stiffness
Individuals who trained for and completed their first marathon experienced improved BP and aortic stiffness equivalent to an approximate 4-year reduction in vascular age, according to research published in the Journal of the American College of Cardiology. Read more.